Literature DB >> 27609770

Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions.

Michael Camilleri1, Ibironke Oduyebo2, Houssam Halawi2.   

Abstract

Several chemical and molecular factors in the intestine are reported to be altered and to have a potentially significant role in irritable bowel syndrome (IBS), particularly in IBS with diarrhea. These include bile acids; short-chain fatty acids; mucosal barrier proteins; mast cell products such as histamine, proteases, and tryptase; enteroendocrine cell products; and mucosal mRNAs, proteins, and microRNAs. This article reviews the current knowledge and unanswered questions in the pathobiology of the chemical and molecular factors in IBS. Evidence continues to point to significant roles in pathogenesis of these chemical and molecular mechanisms, which may therefore constitute potential targets for future research and therapy. However, it is still necessary to address the interaction between these factors in the gut and to appraise how they may influence hypervigilance in the central nervous system in patients with IBS.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  bile; histamine; mRNA; miRNA; mucosal expression; permeability; proteases; short-chain fatty acids; tryptase

Mesh:

Substances:

Year:  2016        PMID: 27609770      PMCID: PMC5130552          DOI: 10.1152/ajpgi.00242.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  60 in total

1.  Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.

Authors:  Michael Camilleri; Paula Carlson; Andres Acosta; Irene Busciglio
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-04-30       Impact factor: 4.052

2.  RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study.

Authors:  Michael Camilleri; Paula Carlson; Andres Acosta; Irene Busciglio; Asha A Nair; Simon J Gibbons; Gianrico Farrugia; Eric W Klee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-24       Impact factor: 4.052

Review 3.  Peripheral mechanisms in irritable bowel syndrome.

Authors:  Michael Camilleri
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

4.  SCFA increase intestinal Na absorption by induction of NHE3 in rat colon and human intestinal C2/bbe cells.

Authors:  M W Musch; C Bookstein; Y Xie; J H Sellin; E B Chang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-04       Impact factor: 4.052

5.  Soluble mediators released from PI-IBS patients' colon induced alteration of mast cell: involvement of reactive oxygen species.

Authors:  Wei Han; Xuefeng Lu; Xiaoqing Jia; Tao Zhou; Chenghao Guo
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

6.  Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  H Duboc; D Rainteau; S Rajca; L Humbert; D Farabos; M Maubert; V Grondin; P Jouet; D Bouhassira; P Seksik; H Sokol; B Coffin; J M Sabaté
Journal:  Neurogastroenterol Motil       Date:  2012-02-22       Impact factor: 3.598

7.  Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.

Authors:  Sabine Buhner; Qin Li; Sheila Vignali; Giovanni Barbara; Roberto De Giorgio; Vincenzo Stanghellini; Cesare Cremon; Florian Zeller; Rupert Langer; Hannelore Daniel; Klaus Michel; Michael Schemann
Journal:  Gastroenterology       Date:  2009-07-28       Impact factor: 22.682

8.  Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome.

Authors:  Magdy El-Salhy; Jan Gunnar Hatlebakk; Odd Helge Gilja; Trygve Hausken
Journal:  Peptides       Date:  2015-03-09       Impact factor: 3.750

9.  Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.

Authors:  K Gecse; R Róka; L Ferrier; M Leveque; H Eutamene; C Cartier; A Ait-Belgnaoui; A Rosztóczy; F Izbéki; J Fioramonti; T Wittmann; L Bueno
Journal:  Gut       Date:  2008-01-14       Impact factor: 23.059

10.  BDNF contributes to IBS-like colonic hypersensitivity via activating the enteroglia-nerve unit.

Authors:  Peng Wang; Chao Du; Fei-Xue Chen; Chang-Qing Li; Yan-Bo Yu; Ting Han; Suhail Akhtar; Xiu-Li Zuo; Xiao-Di Tan; Yan-Qing Li
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

View more
  8 in total

Review 1.  Pharmacogenetics and the treatment of functional gastrointestinal disorders.

Authors:  Houssam Halawi; Michael Camilleri
Journal:  Pharmacogenomics       Date:  2017-07-07       Impact factor: 2.533

Review 2.  What's in the pipeline for lower functional gastrointestinal disorders in the next 5 years?

Authors:  Michael Camilleri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-08-28       Impact factor: 4.052

3.  Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.

Authors:  Prashant Singh; Jocelyn Silvester; Xinhua Chen; Hua Xu; Veer Sawhney; Vikram Rangan; Johanna Iturrino; Judy Nee; Donald R Duerksen; Anthony Lembo
Journal:  United European Gastroenterol J       Date:  2019-01-19       Impact factor: 4.623

4.  Sigmoid colon mucosal gene expression supports alterations of neuronal signaling in irritable bowel syndrome with constipation.

Authors:  Elizabeth J Videlock; Swapna Mahurkar-Joshi; Jill M Hoffman; Dimitrios Iliopoulos; Charalabos Pothoulakis; Emeran A Mayer; Lin Chang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-22       Impact factor: 4.871

5.  Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  Nelson Valentin; Michael Camilleri; Paula Carlson; Sean C Harrington; Deborah Eckert; Jessica O'Neill; Duane Burton; Jun Chen; Audrey L Shaw; Andres Acosta
Journal:  Physiol Rep       Date:  2017-03

6.  Role of stem cell growth factor/c-Kit in the pathogenesis of irritable bowel syndrome.

Authors:  Yuna Chai; Yusheng Huang; Hongmei Tang; Xing Tu; Jianbo He; Ting Wang; Qingye Zhang; Fen Xiong; Detang Li; Zhenwen Qiu
Journal:  Exp Ther Med       Date:  2017-02-20       Impact factor: 2.447

Review 7.  Gut Microbial Metabolites and Biochemical Pathways Involved in Irritable Bowel Syndrome: Effects of Diet and Nutrition on the Microbiome.

Authors:  Shanalee C James; Karl Fraser; Wayne Young; Warren C McNabb; Nicole C Roy
Journal:  J Nutr       Date:  2020-05-01       Impact factor: 4.798

8.  Cannabinoid Receptors Overexpression in a Rat Model of Irritable Bowel Syndrome (IBS) after Treatment with a Ketogenic Diet.

Authors:  Isabella Gigante; Valeria Tutino; Francesco Russo; Valentina De Nunzio; Sergio Coletta; Raffaele Armentano; Alberto Crovace; Maria Gabriella Caruso; Antonella Orlando; Maria Notarnicola
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.